National Health upgraded by Wells Fargo with a new price target
$NHI
Real Estate Investment Trusts
Real Estate
Wells Fargo upgraded National Health from Equal Weight to Overweight and set a new price target of $63.00 from $55.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/1/2024 | $81.00 → $86.00 | Overweight → Equal Weight | Wells Fargo |
| 9/24/2024 | $92.00 | Buy | BofA Securities |
| 3/12/2024 | $67.00 | Market Perform → Outperform | BMO Capital Markets |
| 2/26/2024 | $55.00 → $63.00 | Equal Weight → Overweight | Wells Fargo |
| 2/26/2024 | $57.00 → $64.00 | Neutral → Outperform | Wedbush |
| 1/30/2024 | $69.00 | Buy | Deutsche Bank |
| 10/3/2023 | $54.00 | Neutral | Wedbush |
| 9/28/2023 | $54.00 | Hold | Berenberg |
Wells Fargo downgraded National Health from Overweight to Equal Weight and set a new price target of $86.00 from $81.00 previously
BofA Securities initiated coverage of National Health with a rating of Buy and set a new price target of $92.00
BMO Capital Markets upgraded National Health from Market Perform to Outperform and set a new price target of $67.00
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
Believes NHC faces three potential outcomes with the NHI lease renewal – all of which could lead to a significant decline in NHC earnings and likely material share price weakness NHC may lose 19% to 38% of EBITDA with substantial downside and reputational risk if the company overplays its hand Believes recent developments put NHI in catbird seat in renegotiation and company could see a 12% increase in annual FFO/share when rents are marked to market with potentially more upside if released to a best-in-class operator Today, Land & Buildings Investment Management, LLC (together with its affiliates, "Land & Buildings") issued the following statement: "National Healthcare Corporation's
Land & Buildings Investment Management, LLC (together with its affiliates, "Land & Buildings"), a significant stockholder of National Health Investors, Inc. (NYSE:NHI) ("NHI" or the "Company"), issued the following statement in connection with the Company's 2025 Annual Meeting of Stockholders (the "2025 Annual Meeting"). "We want to thank our fellow stockholders and the leading proxy advisory firms for their support and dialogue throughout this campaign. Based on preliminary results, Land & Buildings fell just short of gaining a board seat for its nominees, with a margin of about 1% of the outstanding shares. While we are disappointed with the outcome, we recognize the Company has made imp
Both Leading Independent Proxy Advisory Firms – ISS and Glass Lewis – Now Recommend Voting FOR Both of Land & Buildings' Independent Nominees Jim Hoffmann and Adam Troso ISS Highlights NHI's "Remarkably Reactive and Defensive" Approach to Corporate Governance and Concludes It Is Unlikely to Improve Without "Fewer Directors With Ties to NHC" Notes NHI's "Governance Gaffes" and "Reactive Reversals" Do Not Inspire Confidence Among Stockholders and That Interlocking Relationships With NHC Have Hurt Profitability Determines Land & Buildings' Nominees Possess the Necessary Independence and Relevant Experience to Support Value-Enhancing Change in the Boardroom Land & Buildings Urges NHI Stockh
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)